|This Slide: #54 of 100|
Slide #54. STERIS Corporation — Integrated Medical Systems International, Inc.
STERIS Corporation (NYSE:STE)
Integrated Medical Systems International, Inc.
STERIS Corporation (NYSE:STE) today announced a definitive agreement to acquire Integrated Medical Systems International, Inc. (IMS) for a purchase price of approximately $165 million, plus approximately $10 million for the purchase of real estate. IMS, a privately held business, is an endoscope repair, surgical instrument management and sterile processing consulting company. IMS revenue for the current calendar year is anticipated to be approximately $150 million.
STERIS is a provider of infection prevention and other procedural products and services. Co. has three business segments: Healthcare, which provides infection prevention and procedural products and services for healthcare providers worldwide, including consumable products, equipment maintenance and installation services, and capital equipment; Applied Sterilization Technologies, which provides contract sterilization and testing services for medical device and pharmaceutical manufacturers; and Life Sciences, which designs, manufactures and sells consumable products, equipment maintenance, other services and capital equipment primarily to pharmaceutical manufacturers around the world.
STE SEC Filing Email Alerts Service
Open the STE Page at The Online Investor »
Strong Buy (3.80 out of 4)